42388
73211
ITI Pharma and Healthcare Fund Growth
19.63
3.21
2.36
0.30
7.16
5.88
11.79
https://storage.googleapis.com/5paisa-prod-storage/files/2024-10/iti.png
7
1.71
19.63
ITI Pharma and Healthcare Fund (G)
1.71
19.63
1.11
3.5
3 Years
ITI Pharma and Healthcare Fund Growth
-
NAV
16.67
09 Jun 2026
-
1.00%
1 Day
-
19.63%
3Y CAGR returns
-
₹ 500
Min SIP -
₹ 5000
Min Lumpsum -
2.38%
Expense Ratio -
230 Cr
Fund Size -
4 Years
Fund Age
SIP Calculator
₹
₹
Yr
- Invested Amount
- ₹ 00
- Wealth Gained
- ₹ 00
- Expected Amount
- ₹ 00
₹
Yr
- Invested Amount
- ₹ 00
- Wealth Gained
- ₹ 00
- Expected Amount
- ₹ 00
Returns and Ranks ( as on 09 Jun 2026 )
- 1Y Returns
- 3Y Returns
- 5Y Returns
- MAX Returns
- Trailing Returns
- 3.21%
- 19.63%
- 11.79
- -3.57Alpha
- 4.73SD
- 0.92Beta
- 0.68Sharpe
- Exit Load
- If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL
- Tax implication
- Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Animesh Singh
Low
Low to
moderate Moderate Moderately
High High Very
High
moderate Moderate Moderately
High High Very
High
- Fund Name
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 7,898
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 8,724
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 8,636
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 230
-
- Equity
- Sectoral / Thematic
- Fund Size (Cr.) - ₹ 7,442
73211
- Fund Name
-
- Equity
- Small Cap Fund
- AUM - ₹ 2,937
-
ITI Mid Cap Fund Growth
- 21.65
-
- Equity
- Mid Cap Fund
- AUM - ₹ 1,358
-
- Equity
- Sectoral / Thematic
- AUM - ₹ 230
-
- Equity
- Flexi Cap Fund
- AUM - ₹ 1,290
-
- Equity
- Multi Cap Fund
- AUM - ₹ 1,365
- Address :
- ITI House 36, Dr.R.K.Shirodkar Marg, Parel Mumbai - 400012.
-
- Contact :
- +91022-66214999
-
- Email ID :
- mfassist@itiorg.com
Mutual Fund by Category
Large Cap
- Fund Name
Quant Large Cap Fund Growth
- 15.43%
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 3,112
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 213
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 1,722
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 51,690
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 75,650
Mid Cap
Multi Cap
ELSS
Focused
Sectoral / Thematic
Small Cap
Dividend Yield
Ultra Short Duration
Liquid Mutual
Gilt Mutual
Long Duration
Overnight Mutual
Floater Mutual
Arbitrage Mutual
Equity Savings Mutual
Aggressive Hybrid Mutual
Other Calculators
FAQs
ITI Pharma and Healthcare Fund Growth has delivered 12.07% since inception
The NAV of ITI Pharma and Healthcare Fund Growth is ₹16.7296 as of 09 Jun 2026
The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.38 % as of 09 Jun 2026
The AUM of ITI Pharma and Healthcare Fund Growth 229.56 CR as of 09 Jun 2026
The minimum SIP amount of ITI Pharma and Healthcare Fund Growth is 500
The top stock holdings of ITI Pharma and Healthcare Fund Growth are
- Sun Pharma.Inds. - 12.40%
- Divi's Lab. - 8.83%
- Apollo Hospitals - 6.25%
- Max Healthcare - 5.22%
- Torrent Pharma. - 4.82%
The top sectors ITI Pharma and Healthcare Fund Growth has invested in are
- - 0%




